title: Is a step backwards in S-phase-targeted chemotherapy a step forward?
authors.affiliation: Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine Pittsburgh, PA 15260, USA.
authors.forename: Pierre E
authors.initials: PE
authors.lastname: Queiroz de Oliveira
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Tomko
authors.forename: John S
authors.initials: JS
authors.lastname: Lazo
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D016923:Cell Death / Q000187:drug effects; D004247:DNA / Q000096:biosynthesis; D004249:DNA Damage; D006801:Humans; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy / Q000473:pathology; D016196:S Phase / Q000187:drug effects*
chemical_list: D000970:Antineoplastic Agents; D004247:DNA